Vargatef
CAS: 1160294-26-7
Ref. 3D-KWB29426
| 25mg | 67.00 € | ||
| 50mg | 107.00 € | ||
| 100mg | 143.00 € | ||
| 250mg | 268.00 € | ||
| 500mg | 403.00 € |
Product Information
- 2,3-Dihydro-3[[[4-[methyl[2-(4-methyl-1-piperazinyl)acetyl]amino]phenylmethylene]-2-oxo-1H-indole-6-carboxylic acid methyl ester
Nintedanib is a medicinal inhibitor that targets cancer cells by inhibiting protein kinases. It has been shown to be effective against various types of tumors, including leukemia. Nintedanib exerts its anti-cancer effects by disrupting the cell cycle and inducing apoptosis in tumor cells. This drug has been tested on human cancer cell lines and has shown promising results in inhibiting tumor growth. Additionally, studies have shown that nintedanib can inhibit angiogenesis, which is the formation of new blood vessels that supply nutrients to tumors. This makes it a potential treatment for cancers that rely on angiogenesis for their growth.
Chemical properties
Technical inquiry about: 3D-KWB29426 Vargatef
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
